What is the optimal first-line treatment for children with chronic inflammatory deruyelinating polyneu-ropathy (CIDP)? It is doubtful that a broadly accepted, evidence-based answer to this question will emerge from this discussion. In addition to the relatively straightforward scientific issues, ...
CIDP Care: A Patient and Clinical Experts Weigh In Emerging Strategies in the Treatment and Management of Idiopathic Pulmonary Fibrosis Hereditary Angioedema: Management Updates for the Specialty Pharmacist JAK Inhibitors Are Important Tools fo...
various forms of connective tissue disorders (eg, lupus, Sjogren's syndrome), and neuropathies associatedwith nutritional deficiencies or toxin exposure, which may complicate diagnosis.2,4 For example, in patients with dia- betes, CIDP must be distinguished from diabetic neuropa- thy and neuropathy...